Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Advanced Cancers × Cetuximab × Clear all

Phase

Status

Completed 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 12 Head and Neck Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Squamous Cell 3 Carcinoma, Non-Small-Cell Lung 3 Recurrence 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Laryngeal Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Endometrial Neoplasms 1 Chordoma 1 Carcinoma 1 Breast Neoplasms 1 Advanced Cancers 1

Interventions

X-Rays 1 Vorinostat 1 Sorafenib 1 Magnetic Resonance Spectroscopy 1 Erlotinib Hydrochloride 1 Curcumin 1 Cetuximab 1 AH 111585 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡